NCT00039780 2022-07-13Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly PaclitaxelBioNumerik Pharmaceuticals, Inc.Phase 3 Completed764 enrolled